Keywords: Tumors, CancerTo further evaluate the efficacy of MRI in the differential diagnosis of glioblastoma (GBM) and primary cerebral lymphoma (PCL), this study retrospectively analysed rCBV and mADC-related data from patients with GBM and PCL and performed a quantitative comparison. The rCBV and mADC values were found to be significantly higher in the GBM group than in the PCL group. We diagnosed GBM when rCBV >23.2900 ml/100g or mADC >0.6550×10-3mm2/s, and the corresponding sensitivity, specificity, and predictive values were all high. This demonstrates the important clinical value of the combined application of mADC and rCBV for the definitive diagnosis of brain tumours.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords